Cellebrite DI Ltd.
NASDAQ:CLBTSoftware - Infrastructure
Technology
$10.65 -0.40%
-$0.05 today
- Market cap
- $2.68B
- Beta
- 1.17
- P/E (TTM)
- 42.6
- EPS (TTM)
- $0.29
52W Low $11.02High $19.98
Volume 3.48M
Average 2.08M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$168.96M
FY 2025 · Annual
+27.8% YoYInvesting Cash Flow
-$268.25M
FY 2025 · Annual
Financing Cash Flow
$29.64M
FY 2025 · Annual
+43.5% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 71.4M | 120.81M | (81.1M) | (283.01M) | 78.33M |
| Depreciation & Amortization | 7.01M | 9.19M | 10.01M | 10.61M | 11.87M |
| Deferred Income Tax | (1.64M) | (2.39M) | 5.13M | (4.02M) | 75K |
| Stock-Based Compensation | 6.48M | 13.71M | 19M | 30.58M | 0 |
| Change in Working Capital | 20.68M | (2.82M) | 38.52M | 42.05M | 42.02M |
| Accounts Receivables | (1.96M) | (12.89M) | 2.27M | (5.83M) | (15.78M) |
| Inventory | (1.8M) | (3.68M) | 243K | 982K | 1.63M |
| Accounts Payables | 4.24M | (5.47M) | 3.69M | 2.76M | 9.19M |
| Other Working Capital | 20.2M | 19.22M | 32.31M | 44.14M | 46.98M |
| Other Non-Cash Items | (67.87M) | (117.92M) | 110.51M | 335.96M | 36.67M |
| Operating Cash Flow | 36.05M | 20.58M | 102.06M | 132.17M | 168.96M |
| Capital Expenditures | (8.11M) | (9.09M) | (7.92M) | (10.61M) | (13.23M) |
| Acquisitions (Net) | (20M) | 0 | 0 | (2.75M) | (147.46M) |
| Purchases of Investments | (21M) | (165.36M) | (144.32M) | (334.79M) | (321.23M) |
| Sales of Investments | 94.34M | 83.22M | 129.7M | 198.67M | 212.8M |
| Other Investing Activities | (3M) | (2.19M) | (2.69M) | (2.04M) | 861K |
| Investing Cash Flow | 45.23M | (91.23M) | (22.54M) | (149.47M) | (268.25M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 4.59M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 25.05M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (100M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 31.6M | 13.97M | 21.77M | 20.65M | 0 |
| Financing Cash Flow | (68.4M) | 13.97M | 21.77M | 20.65M | 29.64M |
| Effect of Forex Changes | (754K) | (1.64M) | 589K | (1.21M) | 2.45M |
| Net Change in Cash | 12.13M | (58.33M) | 101.87M | 2.14M | (67.2M) |
| Free Cash Flow | 27.94M | 11.49M | 94.14M | 121.56M | 155.73M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$78.3M
+ D&A$11.9M
+ Stock-Based Comp$0
+ Deferred Tax$75.0K
+ Working Capital$42.0M
+ Other Non-Cash$36.7M
= Operating Cash Flow$169.0M
- Capex-$13.2M
= Free Cash Flow$155.7M
Analysis
FY2025 free cash flow is $155.7M. FCF conversion is 198.8% of net income. Operating cash flow was $169.0M, with capex of -$13.2M. The largest bridge item is Working Capital at $42.0M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 6-K | 6-K filing | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 19, 2026 | |
| SC 13G | SC 13G filing | Oct 9, 2026 |
Does CLBT generate free cash flow?
Cellebrite DI Ltd. (CLBT) generated $155.73M of free cash flow in fiscal 2025.
How much operating cash flow does CLBT produce?
Operating cash flow was $168.96M, before capital expenditures of $13.22M.
Continue the stock analysis
Jump to another research area for this company.